136 related articles for article (PubMed ID: 20618279)
1. Public hospital admissions for treating complications of clinical care: incidence, costs and funding strategy.
McNair P; Jackson T; Borovnicar D
Aust N Z J Public Health; 2010 Jun; 34(3):330-3. PubMed ID: 20618279
[TBL] [Abstract][Full Text] [Related]
2. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
3. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
Centers for Medicare and Medicaid Services (CMS), HHS
Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
[TBL] [Abstract][Full Text] [Related]
4. Prospective payment to encourage system wide quality improvement.
McNair P; Borovnicar D; Jackson T; Gillett S
Med Care; 2009 Mar; 47(3):272-8. PubMed ID: 19194336
[TBL] [Abstract][Full Text] [Related]
5. Surgical adverse events, risk management, and malpractice outcome: morbidity and mortality review is not enough.
Morris JA; Carrillo Y; Jenkins JM; Smith PW; Bledsoe S; Pichert J; White A
Ann Surg; 2003 Jun; 237(6):844-51; discussion 851-2. PubMed ID: 12796581
[TBL] [Abstract][Full Text] [Related]
6. Clinical redesign using all patient refined diagnosis related groups.
Sedman AB; Bahl V; Bunting E; Bandy K; Jones S; Nasr SZ; Schulz K; Campbell DA
Pediatrics; 2004 Oct; 114(4):965-9. PubMed ID: 15466092
[TBL] [Abstract][Full Text] [Related]
7. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay.
Allman RM; Goode PS; Burst N; Bartolucci AA; Thomas DR
Adv Wound Care; 1999; 12(1):22-30. PubMed ID: 10326353
[TBL] [Abstract][Full Text] [Related]
8. The cost of nurse-sensitive adverse events.
Pappas SH
J Nurs Adm; 2008 May; 38(5):230-6. PubMed ID: 18469616
[TBL] [Abstract][Full Text] [Related]
9. The DRG hospital payment system, surgical readmissions and cost containment.
Munoz E; Goldstein J; Lory MH; Brewster JG; Johnson H; Kahn BA; Wise L
Am Surg; 1990 Nov; 56(11):683-7. PubMed ID: 2122786
[TBL] [Abstract][Full Text] [Related]
10. The costs and adverse events associated with hospitalization of patients with spinal cord injury in Victoria, Australia.
New PW; Jackson T
Spine (Phila Pa 1976); 2010 Apr; 35(7):796-802. PubMed ID: 20228702
[TBL] [Abstract][Full Text] [Related]
11. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
Becker ER
J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
[TBL] [Abstract][Full Text] [Related]
12. Do older Medicare patients cost hospitals more? Evidence from an academic medical center.
Rosenthal GE; Landefeld CS
Arch Intern Med; 1993 Jan; 153(1):89-96. PubMed ID: 8422203
[TBL] [Abstract][Full Text] [Related]
13. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and cost of musculoskeletal disorders: a population-based, public hospital system healthcare consumption approach.
Osborne RH; Nikpour M; Busija L; Sundararajan V; Wicks IP
J Rheumatol; 2007 Dec; 34(12):2466-75. PubMed ID: 17985399
[TBL] [Abstract][Full Text] [Related]
15. Suitability of casemix classification for output funding of blood services in Victoria. Victorian Blood Users Group.
Whyte GS; Brook CW
Med J Aust; 1998 Oct; 169(8):415-8. PubMed ID: 9830388
[TBL] [Abstract][Full Text] [Related]
16. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
17. [Bottom-up analysis of the case costs of stem cell transplantation and selected chemotherapies].
Stäbler W; Wagner B
Klin Padiatr; 2003; 215(3):179-84. PubMed ID: 12778360
[TBL] [Abstract][Full Text] [Related]
18. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
19. Impact of a DRG-based hospital financing system on quality and outcomes of care in Italy.
Louis DZ; Yuen EJ; Braga M; Cicchetti A; Rabinowitz C; Laine C; Gonnella JS
Health Serv Res; 1999 Apr; 34(1 Pt 2):405-15. PubMed ID: 10199684
[TBL] [Abstract][Full Text] [Related]
20. Readmission for neonatal jaundice in California, 1991-2000: trends and implications.
Burgos AE; Schmitt SK; Stevenson DK; Phibbs CS
Pediatrics; 2008 Apr; 121(4):e864-9. PubMed ID: 18381515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
